Other advantages of CA 125 over NT-pro BNP can be of a logistical nature, e.g., CA 125 is widely available as it has already been used as a cancer marker for several decades and the cost of assessment is lower than for natriuretic peptides (Figure 3). The gene discussed is NPPB; the disease is cancer.